<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clindamycin and benzoyl peroxide: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clindamycin and benzoyl peroxide: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Clindamycin and benzoyl peroxide: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="12229" href="/d/html/12229.html" rel="external">see "Clindamycin and benzoyl peroxide: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="12548" href="/d/html/12548.html" rel="external">see "Clindamycin and benzoyl peroxide: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F152776"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Acanya;</li>
<li>BenzaClin with Pump [DSC];</li>
<li>BenzaClin [DSC];</li>
<li>Neuac;</li>
<li>Onexton</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52911960"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>BenzaClin;</li>
<li>Clindoxyl;</li>
<li>Clindoxyl ADV;</li>
<li>TARO-Benzoyl/Clindamycin Kit;</li>
<li>TARO-Clindamycin/Benzoyl Perox</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F152791"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Acne Products;</li>
<li>
                        Topical Skin Product;</li>
<li>
                        Topical Skin Product, Acne</li></ul></div>
<div class="block doa drugH1Div" id="F152779"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a14813b8-cfac-43a7-8cfe-083e79bea0fc">Acne vulgaris</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Acne vulgaris:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Topical:</b></p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Clindamycin 1.2%/benzoyl peroxide 2.5%:</i> Apply pea-sized amount to affected area once daily; use &gt;12 weeks has not been studied.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Clindamycin 1.2%/benzoyl peroxide 3.75%:</i> Apply pea-sized amount to affected area once daily; use &gt;12 weeks has not been studied.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Clindamycin 1%/benzoyl peroxide 5%:</i> Apply to affected area twice daily (morning and evening).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Clindamycin 1.2%/benzoyl peroxide 5%:</i> Apply to affected area once daily in the evening.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="cc3a2a3a-842f-4019-92f3-0d78d87a74b9">Rosacea</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Rosacea (off-label use): Topical:</b>
<i>Clindamycin 1%/benzoyl peroxide 5%:</i> Apply to affected area once daily for 12 weeks (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-15228129']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-15228129'])">Ref</a></span>).</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;margin-top:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dora drugH1Div" id="F50992052"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F50989373"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doe drugH1Div" id="F152780"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F152786"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="12548" href="/d/html/12548.html" rel="external">see "Clindamycin and benzoyl peroxide: Pediatric drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a14813b8-cfac-43a7-8cfe-083e79bea0fc">Acne vulgaris</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Acne vulgaris:</b> Topical: Children ≥7 years and Adolescents: Limited data available in ages &lt;12 years (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23637225']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23637225'])">Ref</a></span>):</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Clindamycin 1.2%/benzoyl peroxide 2.5%:</i> Apply pea-sized amount to affected area once daily; use &gt;12 weeks has not been studied</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Clindamycin 1.2%/benzoyl peroxide 3.75%:</i> Apply pea-sized amount to affected area once daily; use &gt;12 weeks has not been studied</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Clindamycin 1%/benzoyl peroxide 5%:</i> Apply to affected area twice daily (morning and evening)</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="61df1e6b-f829-4d08-a3e1-c59d085f9574">Inflammatory acne</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Inflammatory acne:</b> Topical: Children ≥12 years and Adolescents: Clindamycin 1.2%/Benzoyl peroxide 5%: Apply to affected area once daily in the evening</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dorp drugH1Div" id="F51089944"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block dohp drugH1Div" id="F51089945"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F152754"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Also see individual agents.</p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Application site scaling (≤21%), local dryness (≤16%)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Application site erythema (&lt;31%), local desquamation (2% to 19%), application site itching (≤17%)</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Stinging of the skin (application site: ≤7%), sunburn (local; 1%)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Application site burning (≤10%), application site reaction (3%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%, postmarketing, and/or case reports: Anaphylaxis, application site irritation, application site pain, contact dermatitis, hypersensitivity reaction, local discoloration, local skin exfoliation, skin rash, urticaria</p></div>
<div class="block coi drugH1Div" id="F152765"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to benzoyl peroxide, clindamycin, lincomycin, or any component of the formulation; history of regional enteritis, ulcerative colitis, pseudomembranous colitis or antibiotic-associated colitis </p></div>
<div class="block war drugH1Div" id="F152752"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Bleaching effects: Benzoyl peroxide may bleach hair, colored fabric, or carpeting.</p>
<p style="text-indent:-2em;margin-left:4em;">• Diarrhea: Systemic absorption may occur after topical use of clindamycin. <i>C. difficile</i>-associated diarrhea (CDAD) and pseudomembranous colitis have been reported and have been observed &gt;2 months postantibiotic treatment. Use of parenteral and systemic clindamycin has resulted in severe colitis (including fatalities). Discontinue drug if significant diarrhea, abdominal cramps, or passage of blood and mucus occurs.</p>
<p style="text-indent:-2em;margin-left:4em;">• Hypersensitivity: Anaphylaxis and allergic reactions have been reported, may occur within minutes to a day or longer, and differ from local skin irritation.</p>
<p style="text-indent:-2em;margin-left:4em;">• Skin irritation: Use concomitant topical acne therapy with caution; cumulative irritancy may occur, especially with the use of peeling, desquamating, or abrasive agents.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concurrent drug therapy issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Sulfone products: Concomitant use of benzoyl peroxide with sulfone products (eg, dapsone, sulfacetamide) may cause temporary discoloration (yellow/orange) of facial hair and skin. Application of products at separate times during the day or washing off benzoyl peroxide prior to application of other products may avoid skin discoloration (Dubina 2009).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: For external use only; not for vaginal or ophthalmic use. Avoid contact with mucous membranes. Inform patients to use skin protection and minimize prolonged exposure to sun and avoid tanning beds or sun lamps.</p></div>
<div class="block foc drugH1Div" id="F152760"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Acanya: Clindamycin phosphate 1.2% and benzoyl peroxide 2.5% (50 g) [contains propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">BenzaClin: Clindamycin phosphate 1% and benzoyl peroxide 5% (25 g [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">BenzaClin with Pump: Clindamycin phosphate 1% and benzoyl peroxide 5% (35 g [DSC], 50 g [DSC])</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Neuac: Clindamycin phosphate 1.2% and benzoyl peroxide 5% (45 g) [contains methylparaben, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Onexton: Clindamycin phosphate 1.2% and benzoyl peroxide 3.75% (3.5 g, 50 g) [contains propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Clindamycin phosphate 1% and benzoyl peroxide 5% (25 g, 35 g, 50 g); Clindamycin phosphate 1.2% and benzoyl peroxide 2.5% (50 g); Clindamycin phosphate 1.2% and benzoyl peroxide 3.75% (50 g); Clindamycin phosphate 1.2% and benzoyl peroxide 5% (45 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Kit, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Neuac: Clindamycin phosphate 1.2% and benzoyl peroxide 5% [DSC] [contains cetyl alcohol, edetate (edta) disodium, methylparaben, propylparaben]</p></div>
<div class="block geq drugH1Div" id="F152748"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block fee drugH1Div" id="F152766"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Acanya External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.2-2.5% (per gram): $12.66</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Clindamycin Phos-Benzoyl Perox External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1-5% (per gram): $1.92 - $9.46</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.2-2.5% (per gram): $3.00 - $12.03</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.2-3.75% (per gram): $13.89 - $15.62</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.2-5% (per gram): $1.57 - $4.52</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Neuac External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.2-5% (per gram): $17.66</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Onexton External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1.2-3.75% (per gram): $17.36</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F53666592"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">BenzaClin: Clindamycin phosphate 1% and benzoyl peroxide 5% (50 g)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clindoxyl: Clindamycin phosphate 1% and benzoyl peroxide 5% (45 g) [contains edetate (edta) disodium, methylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clindoxyl ADV: Clindamycin phosphate 1% and benzoyl peroxide 3% (5 g, 45 g) [contains edetate (edta) disodium]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: Clindamycin phosphate 1% and benzoyl peroxide 5% (45 g, 50 g)</p></div>
<div class="block adm drugH1Div" id="F152762"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">Skin should be clean and dry before applying. For external use only; avoid applying to inside nose, mouth, eyes, vagina, mucous membranes, and on areas of broken skin. </p></div>
<div class="block admp drugH1Div" id="F52612434"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">For external use only; not for oral, ophthalmic, or intravaginal use.</p>
<p style="text-indent:-2em;margin-left:2em;">Topical: Skin should be clean and dry before applying. Apply thin layer to affected areas avoiding contact with eyes, lips, inside of nose, mouth, all mucous membranes, and areas of broken skin.</p></div>
<div class="block use drugH1Div" id="F152761"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Acne vulgaris:</b> Topical treatment of acne vulgaris.</p></div>
<div class="block off-label drugH1Div" id="F25873030"><span class="drugH1">Use: Off-Label: Adult</span><p>Rosacea</p></div>
<div class="block cyt drugH1Div" id="F13299059"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F152755"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Aminolevulinic Acid (Systemic): Photosensitizing Agents may enhance the photosensitizing effect of Aminolevulinic Acid (Systemic). <i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Aminolevulinic Acid (Topical): Photosensitizing Agents may enhance the photosensitizing effect of Aminolevulinic Acid (Topical). <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Dapsone (Topical): Benzoyl Peroxide may enhance the adverse/toxic effect of Dapsone (Topical). Specifically, the use of these agents in combination may cause skin and facial hair to temporarily turn a tan or yellow/orange color. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Erythromycin (Systemic): May diminish the therapeutic effect of Clindamycin (Topical). Management: Consider avoiding the concomitant use of systemic erythromycin and topical clindamycin when treating acne vulgaris. This recommendation does not appear to apply to intravaginal use of clindamycin for the treatment of bacterial vaginosis.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Erythromycin (Topical): May diminish the therapeutic effect of Clindamycin (Topical). Management: Consider avoiding use of topical erythromycin and topical clindamycin at the same application site when treating acne vulgaris. This recommendation does not appear to apply to intravaginal use of clindamycin for the treatment of bacterial vaginosis.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Methoxsalen (Systemic): Photosensitizing Agents may enhance the photosensitizing effect of Methoxsalen (Systemic). <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Neuromuscular-Blocking Agents: Clindamycin (Topical) may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Verteporfin: Photosensitizing Agents may enhance the photosensitizing effect of Verteporfin. <i> Risk C: Monitor therapy</i></p></div>
<div class="block pri drugH1Div" id="F152767"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Topical therapy is preferred for the treatment of acne during pregnancy. The combination of topical clindamycin with benzoyl peroxide is recommended for mild to moderate inflammatory acne in pregnant women (Chien 2016).</p>
<p style="text-indent:0em;margin-top:2em;">Refer to individual monographs for additional information.</p></div>
<div class="block brc drugH1Div" id="F152768"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">It is not known if clindamycin or benzoyl peroxide are present in breast milk following topical administration.</p>
<p style="text-indent:-2em;margin-left:2em;">According to the manufacturer, the decision to breastfeed during therapy should consider the risk of infant exposure, the benefits of breastfeeding to the infant, and the benefits of treatment to the mother. Avoid direct infant contact with treated skin.</p>
<p style="text-indent:-2em;margin-left:2em;">Refer to individual monographs for additional information.</p></div>
<div class="block pha drugH1Div" id="F152751"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:-2em;margin-left:2em;">Benzoyl peroxide: Releases free-radical oxygen, which oxidizes bacterial proteins in the sebaceous follicles, decreasing the number of anaerobic bacteria and decreasing irritating-type free fatty acids.</p>
<p style="text-indent:-2em;margin-left:2em;">Clindamycin: Reversibly binds to 50S ribosomal subunits preventing peptide bond formation thus inhibiting bacterial protein synthesis; bacteriostatic or bactericidal depending on drug concentration, infection site, and organism.</p></div>
<div class="block phk drugH1Div" id="F152764"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;display:inline">See individual agents. </p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F854893"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Clindacur uno | Clindoxyl | Cp acne duo multidosis | Duo clindacin | Perclin | Peroxiclin duo</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Clienzo</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Clindamycin/Benzoyl peroxide generichealth | Duac</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Benoxiclin | Clindax b | Duac</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Clindoxyl</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Clidan b | Indoxyl | Klina</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Indoxyl | Sinac</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Duac</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Duac Akne</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Duo clindacin | Indoxyl</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Freeacne | Indoxyl</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Clienzo</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Duac | Duoclin</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Clindamycin Benzoyl Peroxide | Duac Once Daily</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Duac Once Daily | Onexton</span>;</li>
<li>
<span class="countryCode">(HR)</span> <span class="country">Croatia</span><span class="countrySeparator">: </span><span class="drugName">Duac</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Benzolac cl</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Aclind bp | Acnegel b | Clin bp | Clin bpo | Clindoxyl | Clinred b | Clinroz bp | Duoclin b | Nax b | Peroclin | Tyret b</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Duoclin</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Duac</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Benclean | Duac | Ducay</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Benzaclin | Duac</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Duac | Peroclin</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Duac</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Benzaclin | Bpollen duo | Clindapack | Duosight | Indoxyl</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Duac Once Daily</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Clindamycine + benzoylperoxide bmodesto | Clindamycine + Benzoylperoxide Fisher | Duac acne</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Clidan b | Indoxyl</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Duac</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Acnecib | Acnesol | Aimdu | Bencin | Benclin | Boac | Clinazal | Clindaben | Clinzyl | Duac | Hyclin</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Duac | Duac Once Daily</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Acanya | Benzaclin | Clindamycin and benzoyl peroxide | Clindamycin phosphate and benzoyl peroxide | Duac | Neuac | Onexton | Z-Clinz</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Duoclin</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Clidan b | Clindacur uno | Freeacne | Indoxyl</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Duac</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Clindovit combo | Indoxyl</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Duac</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Clindoxyl Once Daily</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Duac Once Daily</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Benzalin | Benzoxin | Clinoper | Clozaril | Oximin</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Duac</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Clidan b | Indoxyl</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Clindoxyl</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Clindoxyl</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Acanya (clindamycin/benzoyl peroxide) [prescribing information]. Bridgewater, NJ: Bausch Health US LLC; February 2020.</div>
</li>
<li>
<div class="reference">
                  Benzaclin (clindamycin/benzoyl peroxide) [prescribing information]. Bridgewater, NJ: Valeant Pharmaceuticals; February 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15117375">
<a name="15117375"></a>Breneman D, Savin R, VandePol C, Vamvakias G, Levy S, Leyden J. Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea. <i>Int J Dermatol</i>. 2004;43(5):381-387.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-and-benzoyl-peroxide-drug-information/abstract-text/15117375/pubmed" id="15117375" target="_blank">15117375</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26957383">
<a name="26957383"></a>Chien AL, Qi J, Rainer B, Sachs DL, Helfrich YR. Treatment of acne in pregnancy.<i> J Am Board Fam Med</i>. 2016;29(2):254-262. doi: 10.3122/jabfm.2016.02.150165.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-and-benzoyl-peroxide-drug-information/abstract-text/26957383/pubmed" id="26957383" target="_blank">26957383</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Duac (clindamycin/benzoyl peroxide) [prescribing information]. Research Triangle Park, NC: Stiefel Laboratories; April 2015.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19770443">
<a name="19770443"></a>Dubina MI, Fleischer AB Jr. Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxide. <i>Arch Dermatol</i>. 2009;145(9):1027-1029. doi:10.1001/archdermatol.2009.186.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-and-benzoyl-peroxide-drug-information/abstract-text/19770443/pubmed" id="19770443" target="_blank">19770443</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23637225">
<a name="23637225"></a>Eichenfield LF, Krakowski AC, Piggott C, et al. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. <i>Pediatrics</i>. 2013;13(1 Suppl 3):S163-186.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-and-benzoyl-peroxide-drug-information/abstract-text/23637225/pubmed" id="23637225" target="_blank">23637225</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20586834">
<a name="20586834"></a>Elewski BE, Draelos Z, Dréno B, Jansen T, Layton A, Picardo M. Rosacea—global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. <i>J Eur Acad Dermatol Venereol</i>. 2011;25(2):188-200.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-and-benzoyl-peroxide-drug-information/abstract-text/20586834/pubmed" id="20586834" target="_blank">20586834</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15228129">
<a name="15228129"></a>Leyden JJ, Thiboutot D, Shalita A. Photographic review of results from a clinical study comparing benzoyl peroxide 5%/clindamycin 1% topical gel with vehicle in the treatment of rosacea. <i>Cutis</i>. 2004;73(6)(suppl):11-17.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-and-benzoyl-peroxide-drug-information/abstract-text/15228129/pubmed" id="15228129" target="_blank">15228129</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Neuac (clindamycin/benzoyl peroxide) [prescribing information]. Allegan, MI: Perrigo; November 2015.</div>
</li>
<li>
<div class="reference">
                  Onexton (clindamycin/benzoyl peroxide) [prescribing information]. Bridgewater, NJ: Bausch Health US LLC; April 2020.</div>
</li></ol></div><div id="topicVersionRevision">Topic 8950 Version 300.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
